Skip to main content
MedPathMedPath Home
Clinical Trials/JPRN-jRCT1030230176
JPRN-jRCT1030230176
Active, not recruiting
未知

Real-World Treatment Patterns and Patient reported outcome in COPD (REMIND)A secondary database study using COPD cohort study in Japan to investigate health status of COPD patients with different inhaler treatment - REMIND

Tashiro Naoki0 sites448 target enrollmentJune 25, 2023
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsCOPD

Overview

Phase
未知
Intervention
Not specified
Conditions
COPD
Sponsor
Tashiro Naoki
Enrollment
448
Status
Active, not recruiting
Last Updated
2 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
June 25, 2023
End Date
TBD
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Tashiro Naoki

Eligibility Criteria

Inclusion Criteria

  • •1\)Patients taken with any of following inhaler treatments ( LAMA, LAMA\+LABA(both single and dual inhaler) or ICS\+LABA(both single and dual inhaler) at cohort entry)

Exclusion Criteria

  • •1\)Patients enrolled at the sites participated in the COPD cohort study where not agreed on secondary use of data for this study

Outcomes

Primary Outcomes

Not specified

Similar Trials

Recruiting
Not Applicable
Real-world clinical characteristics, treatment patterns and outcomes in locally advanced or metastatic non-small cell lung cancer patients in Germany (I-O OPTIMISE/VONKO-014)C34Malignant neoplasm of bronchus and lung
DRKS00031199Bristol Myers Squibb50,000
Completed
Not Applicable
Treatment Reality with Patients' Treatment Response in RE patients treated with low dose of PPIs via Web-based surveyReflux esophagitis
JPRN-UMIN000017268AstraZeneca K.K. Medical1,200
Completed
Not Applicable
Real World Treatment Patterns and Clinical Outcomes in Unfit AML Patients Receiving First Line Systemic Treatment or Best Supportive Care (CURRENT)Acute myeloid leukemia
JPRN-UMIN000037786AbbVie Inc.1,762
Not yet recruiting
Not Applicable
Real world study of Bladder Cancer patients in India
CTRI/2024/06/068713Pfizer Products India Private Limited
Not yet recruiting
Not Applicable
Scientific data review of prostate cancer patients to study treatment patterns and understand need gaps.Health Condition 1: N428- Other specified disorders of prostate
CTRI/2024/08/072504Pfizer Limited